EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT
Xin, Lei, Tan, Yanli, Zhu, Yuanxue, Cui, Xiaoteng, Wang, Qixue, Zhao, Jixing, Tian, Shaohui, Xu, Can, Xiao, Menglin, Hong, Biao, Xu, Jianglong, Yuan, Xiaoye, Wang, Changsheng, Kang, Chunsheng, Fang, Chuan
Published in Neuro-oncology (Charlottesville, Va.) (02.11.2023)
Published in Neuro-oncology (Charlottesville, Va.) (02.11.2023)
Get full text
Journal Article
Incidence and risk of hepatic toxicities with PD-I inhibitors in cancer patients: a meta-analysis
Zhang, Xi, Ran, Yuge, Wang, Kunjie, Zhu, Yuanxue, Li, Jinghua
Published in Drug design, development and therapy (01.01.2016)
Published in Drug design, development and therapy (01.01.2016)
Get full text
Journal Article
Incidence and risk of hepatic toxicities with PD-1 inhibitors in cancer patients: a meta-analysis
Zhang, Xi, Ran, Yuge, Wang, Kunjie, Zhu, Yuanxue, Li, Jinghua
Published in Drug design, development and therapy (01.01.2016)
Published in Drug design, development and therapy (01.01.2016)
Get full text
Journal Article